Major pharmaceutical corporations in India wish to invest in an industrial park producing pharmaceutical products in Vietnam, with an initial investment capital of US$ 500 million.

Indian companies are turning their focus to Vietnam as the country is emerging as one of the bright stars in the COVID-19 dark sky.